Javara and Tryon Medical Partners to Build Robust Clinical Offering
Javara and Tryon Medical Partners have announced that they have formed a collaboration to offer industry-sponsored, outpatient clinical trials to Tryon Medical Partners’ patients.
“This partnership is a win-win for both our patients and doctors,” said Dr. Dale Owen, CEO of Tryon Medical Partners and a cardiologist with the practice. “Our patients will now have an opportunity to directly participate in advanced medical trials at no cost, and our doctors will be able to work closely with Javara’s medical professionals on the development of an array of innovative new drugs and interventions. It is also another significant milestone in Tryon’s rapid growth and development since we opened our first of eight clinics in the Charlotte region last September,” Owen added.
Javara’s Clinical Trial Navigators will be embedded within Tryon’s clinics in South Park and Uptown and work alongside Tryon’s doctors and medical staff. Javara and Tryon will initially conduct clinical trials in internal medicine, endocrinology and dermatology. The team expects initial trials to begin in September 2019, and to grow to have 35 to 45 clinical trials underway within the first 18 months.
“Javara is very pleased to be partnering with the Tryon Medical Partners team to incorporate clinical research into their care offerings to patients and we are eager to get started,” said Jennifer Byrne, CEO of Javara. “We have watched Dr. Owen and his fellow doctors with great interest since they formed an independent practice last year, and believe we have found the perfect partner to work with in the Charlotte region to better integrate clinical research as part of care options for patients.”
The trials are part of the testing required by the Federal Drug Administration before new drugs or devices are approved for broad use with patients.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
